HEp2 ANA EIA: A new fully automated assay for the screening of antinuclear antibodies

Israel Medical Association Journal

Volumn 2, Issue 8, 2000, Pages 646-648

  Lehmann, H P ^a   Fuhling, I ^a   Ott, C ^a   Hudepohl, B ^a   Haass, M ^a  

^a ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Antinuclear antibodies; Automated screening; Diagnostics; Enzyme immunoassay; Systemic autoimmune diseases

Indexed keywords

ANTIGEN; ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; POLYSTYRENE; RECOMBINANT PROTEIN;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOMYOSITIS; ENZYME IMMUNOASSAY; EUROPE; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; POLYMYOSITIS; SCLERODERMA; SJOEGREN SYNDROME; SYNDROME CREST; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; DERMATOMYOSITIS; HUMANS; IMMUNOENZYME TECHNIQUES; POLYMYOSITIS; RHEUMATIC DISEASES; SENSITIVITY AND SPECIFICITY;

EID: 0033844301     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Clinical significance of antinuclear antibodies in systemic rheumatic diseases
2. Concise review for primary care physicians
3. Connective tissue disorders
4. Autoantibodies in the diagnosis of systemic rheumatic diseases
5. Antinuclear antibodies
6. Antinuclear antibodies
7. Antinuclear antibodies